334 related articles for article (PubMed ID: 23556501)
1. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
Li RY; Wan Z; Wang AP; Shen YN; Lu CM; Li M; Xi LY; Liu WD; Zeng FQ
Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
[TBL] [Abstract][Full Text] [Related]
4. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent.
Uchida K; Nishiyama Y; Yamaguchi H
J Infect Chemother; 2004 Aug; 10(4):216-9. PubMed ID: 15365862
[TBL] [Abstract][Full Text] [Related]
6. [Increasing frequency of onychomycoses--is there a change in the spectrum of infectious agents?].
Ginter G; Rieger E; Heigl K; Propst E
Mycoses; 1996; 39 Suppl 1():118-22. PubMed ID: 8767283
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the in vitro activity of terbinafine.
Jessup CJ; Ryder NS; Ghannoum MA
Med Mycol; 2000 Apr; 38(2):155-9. PubMed ID: 10817232
[TBL] [Abstract][Full Text] [Related]
8. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B
Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
Wildfeuer A; Seidl HP; Paule I; Haberreiter A
Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytes.
Shams-Ghahfarokhi M; Shokoohamiri MR; Amirrajab N; Moghadasi B; Ghajari A; Zeini F; Sadeghi G; Razzaghi-Abyaneh M
Fitoterapia; 2006 Jun; 77(4):321-3. PubMed ID: 16690223
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method.
Perea S; Fothergill AW; Sutton DA; Rinaldi MG
J Clin Microbiol; 2001 Jan; 39(1):385-8. PubMed ID: 11136808
[TBL] [Abstract][Full Text] [Related]
13. Fungal infections of the skin: infection process and antimycotic therapy.
Borgers M; Degreef H; Cauwenbergh G
Curr Drug Targets; 2005 Dec; 6(8):849-62. PubMed ID: 16375669
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Marco F; Pfaller MA; Messer SA; Jones RN
Med Mycol; 1998 Dec; 36(6):433-6. PubMed ID: 10206756
[TBL] [Abstract][Full Text] [Related]
15. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
Marangon FB; Miller D; Giaconi JA; Alfonso EC
Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
[TBL] [Abstract][Full Text] [Related]
16. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
[TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study.
Piérard GE; Arrese JE; De Doncker P
J Am Acad Dermatol; 1995 Mar; 32(3):429-35. PubMed ID: 7868711
[TBL] [Abstract][Full Text] [Related]
18. Drug therapy in otomycosis: an in vitro study.
Lawrence TL; Ayers LW; Saunders WH
Laryngoscope; 1978 Nov; 88(11):1755-60. PubMed ID: 713671
[TBL] [Abstract][Full Text] [Related]
19. In vitro antifungal activity of sertaconazole against 309 dermatophyte clinical isolates.
Carrillo-Muñoz AJ; Fernandez-Torres B; Guarro J
J Chemother; 2003 Dec; 15(6):555-7. PubMed ID: 14998079
[TBL] [Abstract][Full Text] [Related]
20. [New antifungal agents in the treatment of superficial dermatomycoses].
Degreef H
Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
